Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Tebas P

Collect these papers and discover other ones on Labmeeting. Learn more.

Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men.

+ cite this

+ View Abstract

Lo Re V, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, and Tebas P

AIDS (London, England) 23(16):2191-8, 2009 Oct 23 - Who cited this? | PubMed ID: 19779322 | Fulltext

Hepatitis C virus treatment: the beginning of a new era.

+ cite this

Tebas P

Current HIV/AIDS reports 6(3):117-8, 2009 Aug - Who cited this? | PubMed ID: 19589296 | Fulltext

Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.

+ cite this

+ View Abstract

Tebas P, Zhang J, Hafner R, Tashima K, Shevitz A, Yarasheski K, Berzins B, Owens S, Forand J, Evans S, and Murphy R

The Journal of antimicrobial chemotherapy 63(5):998-1005, 2009 May - Who cited this? | PubMed ID: 19299471 | Fulltext

Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells.

+ cite this

+ View Abstract

Wang GP, Levine BL, Binder GK, Berry CC, Malani N, McGarrity G, Tebas P, June CH, and Bushman FD

Molecular therapy : the journal of the American Society of Gene Therapy 17(5):844-50, 2009 May - Who cited this? | PubMed ID: 19259065 | Fulltext

Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.

+ cite this

+ View Abstract

Guaraldi G, Ventura P, Garlassi E, Orlando G, Squillace N, Nardini G, Stentarelli C, Zona S, Marchini S, Moriondo V, and Tebas P

HIV medicine 10(1):28-34, 2009 Jan - Who cited this? | PubMed ID: 19125962 | Fulltext

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

+ cite this

+ View Abstract

Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF,

(show remaining authors)

The New England journal of medicine 359(14):1442-55, 2008 Oct 2 - Who cited this? | PubMed ID: 18832245 | Fulltext

The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana.

+ cite this

+ View Abstract

Bisson GP, Nthobatsong R, Thakur R, Lesetedi G, Vinekar K, Tebas P, Bennett JE, Gluckman S, Gaolathe T, and MacGregor RR

Journal of acquired immune deficiency syndromes (1999) 49(2):227-229, 2008 Oct - Who cited this? | PubMed ID: 18769344 | Fulltext

HIV-1 Nef induces Programmed Death (PD)-1 expression through a p38 MAPK dependent mechanism.

+ cite this

+ View Abstract

Muthumani K, Choo AY, Shedlock DJ, Laddy DJ, Sundaram SG, Hirao L, Wu L, Thieu KP, Chung CW, Lankaram KM, Tebas P, Silvestri G, and Weiner DB

Journal of virology, 2008 Sep 25 - Who cited this? | PubMed ID: 18799583 | Fulltext

HIV and cardiometabolic abnormalities: new perspectives and treatment update.

+ cite this

Tebas P

Journal of acquired immune deficiency syndromes (1999) 49 Suppl 2:S77-8, 2008 Sep 1 - Who cited this? | PubMed ID: 18725815 | Fulltext

Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options.

+ cite this

+ View Abstract

Tebas P

Journal of acquired immune deficiency syndromes (1999) 49 Suppl 2:S86-92, 2008 Sep 1 - Who cited this? | PubMed ID: 18725817 | Fulltext

Genetic analysis implicates resistin in HIV lipodystrophy.

+ cite this

+ View Abstract

Ranade K, Geese WJ, Noor M, Flint O, Tebas P, Mulligan K, Powderly W, Grinspoon SK, and Dube MP

AIDS (London, England) 22(13):1561, 2008 Aug 20 - Who cited this? | PubMed ID: 18670214 | Fulltext

Massively parallel pyrosequencing in HIV research.

+ cite this

Bushman FD, Hoffmann C, Ronen K, Malani N, Minkah N, Rose HM, Tebas P, and Wang GP

AIDS (London, England) 22(12):1411, 2008 Jul 31 - Who cited this? | PubMed ID: 18614863 | Fulltext

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.

+ cite this

+ View Abstract

Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dubé M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR, and

The Journal of infectious diseases 197(6):858, 2008 Mar 15 - Who cited this? | PubMed ID: 18419350 | Fulltext

Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function.

+ cite this

+ View Abstract

Tebas P, Bellos N, Lucasti C, Richmond G, Godofsky E, Patel I, Chiu YY, Evans C, Rowell L, and Salgo M

Journal of acquired immune deficiency syndromes (1999) 47(3):342-5, 2008 Mar 1 - Who cited this? | PubMed ID: 18091608 | Fulltext

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.

+ cite this

+ View Abstract

Tebas P, Henry WK, Matining R, Weng-Cherng D, Schmitz J, Valdez H, Jahed N, Myers L, Powderly WG, and Katzenstein D

PLoS ONE 3(4), 2008 - Who cited this? | PubMed ID: 18431498 | Fulltext

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

+ cite this

+ View Abstract

McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, and Wohl DA

AIDS (London, England) 21(18):2473, 2007 Nov 30 - Who cited this? | PubMed ID: 18025884 | Fulltext

Is it time to rethink the expanded-access programs for HIV infection?.

+ cite this

+ View Abstract

Amorosa V and Tebas P

The Journal of infectious diseases 196(7):974-7, 2007 Oct 1 - Who cited this? | PubMed ID: 17763316 | Fulltext

Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.

+ cite this

+ View Abstract

Dubé MP, Komarow L, Mulligan K, Grinspoon SK, Parker RA, Robbins GK, Roubenoff R, Tebas P, and Adult Clinical Trials Group 384

Journal of acquired immune deficiency syndromes (1999) 45(5):508-14, 2007 Aug 15 - Who cited this? | PubMed ID: 17589373 | Fulltext

Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.

+ cite this

+ View Abstract

Dubé MP, Parker RA, Mulligan K, Tebas P, Robbins GK, Roubenoff R, and Grinspoon SK

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45(1):120-6, 2007 Jul 1 - Who cited this? | PubMed ID: 17554712 | Fulltext

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).

+ cite this

+ View Abstract

Tebas P, Zhang J, Yarasheski K, Evans S, Fischl MA, Shevitz A, Feinberg J, Collier AC, Shikuma C, Brizz B, Sattler F, and for the AIDS Clinical Trials Group (ACTG)

Journal of acquired immune deficiency syndromes (1999) 45(2):193-200, 2007 Jun 1 - Who cited this? | PubMed ID: 17527093 | Fulltext

Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.

+ cite this

+ View Abstract

Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani FJ, Tebas P, Li Y, and Hodis HN

AIDS (London, England) 21(9):1137-45, 2007 May 31 - Who cited this? | PubMed ID: 17502724 | Fulltext

Interventions for body habitus changes associated with HIV infection and its treatment.

+ cite this

+ View Abstract

Tebas P

Current HIV/AIDS reports 4(2):86-92, 2007 May - Who cited this? | PubMed ID: 17547830 | Fulltext

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

+ cite this

+ View Abstract

Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB,

(show remaining authors)

Archives of internal medicine 167(6):597, 2007 Mar 26 - Who cited this? | PubMed ID: 17389292 | Fulltext

Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.

+ cite this

+ View Abstract

Re VL, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, and Strom BL

Journal of acquired immune deficiency syndromes (1999) 44(3):315-20, 2007 Mar 1 - Who cited this? | PubMed ID: 17159655 | Fulltext

Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro.

+ cite this

+ View Abstract

Wang X, Douglas SD, Lai JP, Tuluc F, Tebas P, and Ho WZ

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2(1):42-8, 2007 Mar - Who cited this? | PubMed ID: 18040825 | Fulltext

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.

+ cite this

+ View Abstract

Fischl MA, Collier AC, Mukherjee AL, Feinberg JE, Demeter LM, Tebas P, Giuliano M, Dehlinger M, Garren K, Brizz B, and Bassett R

AIDS (London, England) 21(3):325-33, 2007 Jan 30 - Who cited this? | PubMed ID: 17255739 | Fulltext

DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations.

+ cite this

+ View Abstract

Hoffmann C, Minkah N, Leipzig J, Wang G, Arens MQ, Tebas P, and Bushman FD

Nucleic acids research 35(13), 2007 - Who cited this? | PubMed ID: 17576693 | Fulltext

Cardiovascular risks of antiretroviral therapies.

+ cite this

+ View Abstract

Mondy K and Tebas P

Annual review of medicine 58:141-55, 2007 - Who cited this? | PubMed ID: 17217329 | Fulltext

[Delayed diagnosis of HIV infection in the Spanish VACH cohort [1997-2002]].

+ cite this

+ View Abstract

Teira Cobo R, Suárez Lozano I, Santamaría Jáuregui JM, Terrón Pernía A, Domingo Pedrol P, González García J, Cosín Ochaita J, Ribera Pascuet E, Sánchez T, Roca Villanueva B, Viciana Fernández P, García Alcalde ML, Geijo Martínez P, Galindo Puerto P, Vergara Campos A, Lozano de León Naranjo F,

(show remaining authors)

Gaceta sanitaria / S.E.S.P.A.S 21(1):66-9, 2007 - Who cited this? | PubMed ID: 17306189 | Fulltext

Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.

+ cite this

+ View Abstract

Lederman MM, Smeaton L, Smith KY, Rodriguez B, Pu M, Wang H, Sevin A, Tebas P, Sieg SF, Medvik K, Margolis DM, Pollard R, Ertl HC, and Valdez H

The Journal of infectious diseases 194(12):1677-85, 2006 Dec 15 - Who cited this? | PubMed ID: 17109339 | Fulltext

Explaining, predicting, and treating HIV-associated CD4 cell loss: after 25 years still a puzzle.

+ cite this

Henry WK, Tebas P, and Lane HC

JAMA : the journal of the American Medical Association 296(12):1523-5, 2006 Sep 27 - Who cited this? | PubMed ID: 17003402 | Fulltext

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

+ cite this

+ View Abstract

Wohl DA, McComsey G, Tebas P, Brown TT, Glesby MJ, Reeds D, Shikuma C, Mulligan K, Dube M, Wininger D, Huang J, Revuelta M, Currier J, Swindells S, Fichtenbaum C, Basar M,

(show remaining authors)

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43(5):645-53, 2006 Sep 1 - Who cited this? | PubMed ID: 16886161 | Fulltext

Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy.

+ cite this

+ View Abstract

Timmermans EC, Tebas P, Ruiter JP, Wanders RJ, De Ronde A, and de Baar MP

Clinical chemistry 52(6):979, 2006 Jun - Who cited this? | PubMed ID: 16601068 | Fulltext

A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.

+ cite this

+ View Abstract

Henry K, Katzenstein D, Cherng DW, Valdez H, Powderly W, Vargas MB, Jahed NC, Jacobson JM, Myers LS, Schmitz JL, Winters M, Tebas P, and A5102 Study Team of the AIDS Clinical Trials Group

Journal of acquired immune deficiency syndromes (1999) 42(2):140-8, 2006 Jun - Who cited this? | PubMed ID: 16760795 | Fulltext

Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.

+ cite this

+ View Abstract

Mulligan K, Parker RA, Komarow L, Grinspoon SK, Tebas P, Robbins GK, Roubenoff R, and Dubé MP

Journal of acquired immune deficiency syndromes (1999) 41(5):590-7, 2006 Apr 15 - Who cited this? | PubMed ID: 16652032 | Fulltext

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.

+ cite this

+ View Abstract

Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, and Reilly MP

PLoS medicine 3(3):e52, 2006 Mar - Who cited this? | PubMed ID: 16417409 | Fulltext

Management of potential neurocysticercosis in patients with HIV infection.

+ cite this

+ View Abstract

Prasad S, MacGregor RR, Tebas P, Rodriguez LB, Bustos JA, and White AC

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 42(4):e30-4, 2006 Feb 15 - Who cited this? | PubMed ID: 16421784 | Fulltext

Bone disease and HIV infection.

+ cite this

+ View Abstract

Amorosa V and Tebas P

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 42(1):108, 2006 Jan 1 - Who cited this? | PubMed ID: 16323100 | Fulltext

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.

+ cite this

+ View Abstract

Dubé MP, Parker RA, Tebas P, Grinspoon SK, Zackin RA, Robbins GK, Roubenoff R, Shafer RW, Wininger DA, Meyer WA, Snyder SW, and Mulligan K

AIDS (London, England) 19(16):1807-18, 2005 Nov 4 - Who cited this? | PubMed ID: 16227788 | Fulltext

Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease.

+ cite this

+ View Abstract

Kalayjian RC, Spritzler J, Pu M, Landay A, Pollard RB, Stocker V, Harthi LA, Gross BH, Francis IR, Fiscus SA, Tebas P, Bosch RJ, Valcour V, Lederman MM, and Adult AIDS Clinical Trials Group 5015 and 5113 Study Teams

The Journal of infectious diseases 192(9):1577-87, 2005 Nov 1 - Who cited this? | PubMed ID: 16206072 | Fulltext

A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.

+ cite this

+ View Abstract

Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D, Frank I, and Tebas P

Journal of acquired immune deficiency syndromes (1999) 39(5):557-61, 2005 Aug 15 - Who cited this? | PubMed ID: 16044007 | Fulltext

Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.

+ cite this

+ View Abstract

Mondy K, Powderly WG, Claxton SA, Yarasheski KH, Royal M, Stoneman JS, Hoffmann ME, and Tebas P

Journal of acquired immune deficiency syndromes (1999) 38(4):426-31, 2005 Apr 1 - Who cited this? | PubMed ID: 15764959 | Fulltext

Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips".

+ cite this

+ View Abstract

MacGregor RR, Boyer JD, Ugen KE, Tebas P, Higgins TJ, Baine Y, Ciccarelli RB, Ginsberg RS, and Weiner DB

Vaccine 23(17-18):2066-73, 2005 Mar 18 - Who cited this? | PubMed ID: 15755572 | Fulltext

Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care.

+ cite this

+ View Abstract

Fichtenbaum CJ, Hadigan CM, Kotler DP, Pierone G, Sax PE, Steinhart CR, Tebas P, and International Association of Physicians in AIDS Care

IAPAC monthly 11(2):38-46, 2005 Feb - Who cited this? | PubMed ID: 15971353 | Fulltext

Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.

+ cite this

+ View Abstract

Uhlmann EJ, Tebas P, Storch GA, Powderly WG, Lie YS, Whitcomb JM, Hellmann NS, and Arens MQ

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 31(3):198-203, 2004 Nov - Who cited this? | PubMed ID: 15465412 | Fulltext

Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy.

+ cite this

+ View Abstract

Gerber MT, Mondy KE, Yarasheski KE, Drechsler H, Claxton S, Stoneman J, DeMarco D, Powderly WG, and Tebas P

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 39(3):419-25, 2004 Aug 1 - Who cited this? | PubMed ID: 15307011 | Fulltext

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

+ cite this

+ View Abstract

Wang MW, Wei S, Faccio R, Takeshita S, Tebas P, Powderly WG, Teitelbaum SL, and Ross FP

The Journal of clinical investigation 114(2):206, 2004 Jul - Who cited this? | PubMed ID: 15254587 | Fulltext

Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.

+ cite this

+ View Abstract

Tebas P, Yarasheski K, Henry K, Claxton S, Kane E, Bordenave B, Klebert M, and Powderly WG

AIDS research and human retroviruses 20(6):589-94, 2004 Jun - Who cited this? | PubMed ID: 15242534 | Fulltext

Cure of acute hepatitis C in HIV co-infection?.

+ cite this

Ristig MB, Tebas P, Gandy I, Qaqish R, and Aberg JA

Journal of clinical gastroenterology 38(3):303, 2004 Mar - Who cited this? | PubMed ID: 15128087 | Fulltext

Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.

+ cite this

+ View Abstract

Jacobson JM, Lederman MM, Spritzler J, Valdez H, Tebas P, Skowron G, Wang R, Jackson JB, Fox L, Landay A, Gilbert MJ, O'Neil D, Bancroft L, Al-Harthi L, Jacobson MA, Merigan TC,

(show remaining authors)

The Journal of infectious diseases 188(12):1804-14, 2003 Dec 15 - Who cited this? | PubMed ID: 14673758 | Fulltext

Search Google Scholar for Tebas P

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!